The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology
Not Applicable
Withdrawn
- Conditions
- Lung Neoplasm
- Interventions
- Device: LungBrella marker implantation and VATS partial lobe resection
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Ruijin Hospital
- Registration Number
- NCT04529603
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Precise Treatment of Prediabetes and Stage 1 Hypertension
Completed
- Conditions
- Diabetes
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2004
- Registration Number
- NCT04529590
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD
Not Applicable
- Conditions
- Speech DisordersParkinson Disease
- Interventions
- Behavioral: Conventional Speech RehabilitationBehavioral: Yi Jin Jing Tiger Roaring Speech Rehabilitation
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04528147
- Locations
- 🇨🇳
Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital, Shanghai, Shanghai, China
Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Not Applicable
Recruiting
- Conditions
- Rectal CancerColorectal CancerColon Cancer
- Interventions
- Procedure: Single-incision Laparoscopic SurgeryProcedure: Conventional Laparoscopic Surgery
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 710
- Registration Number
- NCT04527861
- Locations
- 🇨🇳
The 940th Hospital of Joint Logistic Support Force of Chinese of PLA, Lanzhou, Gansu, China
🇨🇳Shandong Provincial Hospital, Jinan, Shandong, China
🇨🇳Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma
- Conditions
- Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04525209
- Locations
- 🇨🇳
RUIJIN Hospital, Shanghai, Shanghai, China
ctDNA Screening in Advanced HER2 Positive Gastric Cancer
Recruiting
- Conditions
- HER2-positive Gastric Cancer
- Interventions
- Genetic: ctDNA screening
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04520295
- Locations
- 🇨🇳
Department of Oncology, Ruijin Hospital, Shanghai, China
Accurate Diagnosis of Multiple Sclerosis Using PET/MR
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Diagnostic Test: 18F-florbetapir PET+MRSI
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT04521439
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, China
Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial
Phase 4
- Conditions
- Premature Ventricular Contraction
- Interventions
- Procedure: Catheter Ablation
- First Posted Date
- 2020-08-19
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04519112
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Radiation: omit of IMI groupRadiation: IMI group
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 214
- Registration Number
- NCT04517266
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai jiaotong univestigy school of medicine, Shanghai, Shanghai, China
A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)
Early Phase 1
- Conditions
- Colorectal Cancer Liver MetastasisStage III Colorectal Cancer
- Interventions
- Biological: Anti-CEA-CAR T
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT04513431
© Copyright 2025. All Rights Reserved by MedPath